Results 131 to 140 of about 13,606 (212)

[Increased use of antidepressive agents. A correctly aimed development] [PDF]

, 1997
Isacsson, G,, Bergman, U,
core  

Assessing Practice Patterns of Antidepressant Medication and Tamoxifen Use Among Patients With Hormone Receptor-Positive Breast Cancer. [PDF]

Cancer Rep (Hoboken)
Lopetegui-Lia N, Murray A, Ondeck M, Osantowski B, Takkellapati S, Wei W, Maggiotto A, Moore HCF, Roesch E.   +8 more
europepmc   +1 more source

Overstated association between adolescent physical fitness and adulthood depression risk due to familial factors. [PDF]

J Intern Med
Ballin M, Ekblom Ö, Nordström A, Ahlqvist VH, Nordström P.   +4 more
europepmc   +1 more source

[Sexual dysfunction is common during treatment with antidepressive agents] [PDF]

, 1998
Bodlund, Owe,
core  

Serum inflammatory cytokines in the progression of depression. [PDF]

Front Immunol
Feng Q, Yuan Z, An Q, Wang K, Liu X.
europepmc   +1 more source

Dopamine D2 receptor agonists prevent impairment of maternal care in lipopolysaccharide-induced postpartum depression model mice. [PDF]

J Vet Med Sci
Shimizu H, Sadakuni Y, Muroi Y, Ishii T.
europepmc   +1 more source

Study protocol for the effect of intraoperative subanaesthetic dose esketamine on the incidence of postoperative depressive symptoms in patients with breast cancer: a multicentre, prospective, randomised controlled trial. [PDF]

BMJ Open
Li ZY, Wang J, Yang JS, Xu X, Wang F, Li HX, Zheng H, Fang Y, Ma S, Yan T.   +9 more
europepmc   +1 more source

Protective effects of antidepressants against ulcerogenic agents: insights from nonclinical studies. [PDF]

Inflammopharmacology
Stringari C, Stringari H, de Queiroz E Silva TF, Willrich CH, da Silva LM.   +4 more
europepmc   +1 more source

Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial.

Health Technol Assess
Kerr-Gaffney J, Zenasni Z, Goldsmith K, Yaziji N, Jin H, Colasanti A, Geddes J, Kessler D, McAllister-Williams RH, Young AH, Barrera A, Marwood L, Taylor RW, Tee H, Cleare AJ, LQD Study Group.   +15 more
europepmc   +1 more source

Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far. [PDF]

Front Psychiatry
Diendorfer CM, Bum C, Weidenauer A, Sauerzopf U, Bartova L, Dajic I, Müller L, Rujescu D, Praschak-Rieder N, Willeit M.   +9 more
europepmc   +1 more source